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1. INTRODUCTION {#irv12613-sec-0006}
===============

Infections with influenza A virus (IAV) are widespread among domestic swine populations worldwide. Due to acute respiratory diseases caused by IAV, clinically often enhanced by further viral and bacterial co‐infections, the pork‐producing industry faces substantial economic losses.[1](#irv12613-bib-0001){ref-type="ref"}, [2](#irv12613-bib-0002){ref-type="ref"}, [3](#irv12613-bib-0003){ref-type="ref"}

Influenza A virus belongs to the *Orthomyxoviridae* family and has a genome with eight segments. Subtypes are categorized by the genetic and antigenic properties of the hemagglutinin (HA) and neuraminidase (NA) membrane glycoproteins: 18 HA types (H1‐H18) and 11 NA (N1‐N11) types are distinguished today.[4](#irv12613-bib-0004){ref-type="ref"}, [5](#irv12613-bib-0005){ref-type="ref"} Swine are susceptible to different IAV types, of both avian and human origins, and currently perpetuate autonomous porcine‐adapted lineages of subtypes H1, H3, N1 and N2.[6](#irv12613-bib-0006){ref-type="ref"} In addition, sporadic and dead‐end infections in swine with avian influenza viruses of various subtypes have been reported.[6](#irv12613-bib-0006){ref-type="ref"} All human pandemic IAVs of the 20th century (with the exception of the 1958 H2N2 viruses) and the current century established autonomously circulating lineages in swine populations following human‐to‐swine transmission.[6](#irv12613-bib-0006){ref-type="ref"} The most recent human pandemic virus (H1N1/2009, the so‐called swine flu) was likely derived from Mesoamerican swine populations. This emphasizes the zoonotic risk of swine influenza A viruses (SIV).[7](#irv12613-bib-0007){ref-type="ref"}, [8](#irv12613-bib-0008){ref-type="ref"} Zoonotic (swine‐to‐human) and reverse zoonotic (human‐to‐swine) transmissions of IAV seem to be occurring regularly.[9](#irv12613-bib-0009){ref-type="ref"}, [10](#irv12613-bib-0010){ref-type="ref"}, [11](#irv12613-bib-0011){ref-type="ref"}, [12](#irv12613-bib-0012){ref-type="ref"}

Aside from IAV, there are two further human influenza virus types, influenza B virus (IBV) and influenza C virus (ICV).[13](#irv12613-bib-0013){ref-type="ref"}, [14](#irv12613-bib-0014){ref-type="ref"}, [15](#irv12613-bib-0015){ref-type="ref"} Similar to IAV, influenza B viruses have eight genome segments including genes encoding HA and NA glycoproteins which, however, have evolved only two distinguishable HA lineages so far.[16](#irv12613-bib-0016){ref-type="ref"}, [17](#irv12613-bib-0017){ref-type="ref"}, [18](#irv12613-bib-0018){ref-type="ref"} Like IAV, IBV is regularly involved in seasonal influenza outbreaks in humans but until to date, only three cases of florid IBV infections have been detected.[14](#irv12613-bib-0014){ref-type="ref"}, [19](#irv12613-bib-0019){ref-type="ref"} In Europe, serological studies from the 1960s showed the sporadic presence of antibodies against IBV in domestic pigs in Hungary.[20](#irv12613-bib-0020){ref-type="ref"} More recently, a surveillance for IBV in U.S. Midwest swine farms showed a seroprevalence of 7.3% at the sample and 38.5% at farm level, respectively.[21](#irv12613-bib-0021){ref-type="ref"} Furthermore, the susceptibility of swine for IBV has been demonstrated under experimental conditions with pigs developing influenza‐like symptoms as well as lung lesions. The transmission of the virus to sentinel pigs was also seen in this challenge trial.[21](#irv12613-bib-0021){ref-type="ref"}

Influenza C virus is the third human influenza virus type and is composed of seven genome segments. Instead of HA and NA, this virus expresses a hemagglutinin‐esterase‐fusion (HEF) protein on its surface, conveying both receptor‐binding and ‐destroying functions.[22](#irv12613-bib-0022){ref-type="ref"} It causes only mild diseases in humans, particularly in very young children, and is therefore not included in vaccination schemes.[23](#irv12613-bib-0023){ref-type="ref"}, [24](#irv12613-bib-0024){ref-type="ref"} The only report of an infection in swine came from China in 1981, where ICV was found in 15 samples during a year‐long monitoring at a slaughterhouse. Detections were confined to the winter and spring months, in pigs with no signs of illness.[25](#irv12613-bib-0025){ref-type="ref"}

In 2011, a novel C‐like influenza virus has been described in swine in the United States.[26](#irv12613-bib-0026){ref-type="ref"} Like ICV, it is composed of seven genome segments and presents a HEF protein at the membrane surface. However, the low genetic homology and lack of antibody cross‐reactivity to ICV led to its designation as a new influenza virus type, tentatively named influenza D virus (IDV).[27](#irv12613-bib-0027){ref-type="ref"}, [28](#irv12613-bib-0028){ref-type="ref"} To this day, it was found in swine but more frequently in cattle showing mild respiratory disease suggesting cattle may be the domestic reservoir species for IDV.[29](#irv12613-bib-0029){ref-type="ref"}, [30](#irv12613-bib-0030){ref-type="ref"}, [31](#irv12613-bib-0031){ref-type="ref"} No human cases were discovered thus far though antibodies for IDV were found in people with close contact to cattle and swine, and in vitro studies demonstrated the ability of the virus to grow in human‐derived cells.[32](#irv12613-bib-0032){ref-type="ref"}, [33](#irv12613-bib-0033){ref-type="ref"}, [34](#irv12613-bib-0034){ref-type="ref"}

In the wake of the H1N1pdm/2009 human pandemic, European surveillance projects for swine IAV revealed that four main IAV lineages were in circulation in domestic swine populations in Europe, one of which was of avian and three of human origin.[35](#irv12613-bib-0035){ref-type="ref"} Very little is known concerning the occurrence of IBV, ICV and IDV in European swine populations and other animal hosts.[20](#irv12613-bib-0020){ref-type="ref"}, [21](#irv12613-bib-0021){ref-type="ref"}, [25](#irv12613-bib-0025){ref-type="ref"}, [26](#irv12613-bib-0026){ref-type="ref"}, [27](#irv12613-bib-0027){ref-type="ref"}, [28](#irv12613-bib-0028){ref-type="ref"}, [29](#irv12613-bib-0029){ref-type="ref"}, [30](#irv12613-bib-0030){ref-type="ref"}, [32](#irv12613-bib-0032){ref-type="ref"}, [33](#irv12613-bib-0033){ref-type="ref"}, [34](#irv12613-bib-0034){ref-type="ref"}, [36](#irv12613-bib-0036){ref-type="ref"} In the light of the fact that most of the porcine IAV strains established in swine are of human origin, it is conceivable that this could also be possible for human IBV and ICV.[2](#irv12613-bib-0002){ref-type="ref"}, [3](#irv12613-bib-0003){ref-type="ref"}, [10](#irv12613-bib-0010){ref-type="ref"}, [11](#irv12613-bib-0011){ref-type="ref"}, [35](#irv12613-bib-0035){ref-type="ref"} Similar to IBV and ICV, there is no systematic monitoring of IDV in swine, although a few reports carried out in European countries revealed anecdotical presence of IDV in Luxemburg and Italy in swine with influenza‐like disease.[31](#irv12613-bib-0031){ref-type="ref"}, [32](#irv12613-bib-0032){ref-type="ref"}, [36](#irv12613-bib-0036){ref-type="ref"}

For a better understanding of the epidemiology of IBV, ICV and IDV in swine, a time‐efficient and low‐cost diagnostic tool for large‐scale screening of four influenza virus types was developed here. The influenza ABCD tetraplex reverse transcription real‐time PCR (RT‐qPCR) generically targeting IAV, IBV, ICV and IDV was validated and used to screen 4033 samples from pigs with respiratory disease obtained from 707 farms in twelve European countries.

2. MATERIALS AND METHODS {#irv12613-sec-0007}
========================

2.1. Field samples, reference viruses {#irv12613-sec-0008}
-------------------------------------

A industrial‐funded passive surveillance project for IAV infections in swine targeting 12 different European countries, intended as a follow‐up to the European Surveillance Network for Influenza in Pigs (ESNIP) surveillance programme (Ref. [37](#irv12613-bib-0037){ref-type="ref"}, Henritzi et al., in preparation), was carried out between April 2015 and March 2017. Field samples obtained from 707 farms were taken from domestic pigs of all ages with signs of respiratory illness. In total, 4033 clinical samples, nasal swabs (n = 3963), lung tissues (n = 46), oral fluids (n = 23) and one lung lavage were obtained. Table [1](#irv12613-tbl-0001){ref-type="table"}A and B provides detailed accounts of sample origin. The majority of submissions came from Germany, France and the Netherlands, although the surveillance in Germany started not before July 2016 (Table [1](#irv12613-tbl-0001){ref-type="table"}A). Collection sites are illustrated in Figure [1](#irv12613-fig-0001){ref-type="fig"}A. Samples were processed and analysed for IAV‐RNA by an M‐gene‐specific RT‐qPCR that was modified after 2009 to include the detection of the pandemic H1N1/2009.[38](#irv12613-bib-0038){ref-type="ref"} Additionally, the use of an internal control was added to ensure integrity of extracted RNA and inhibitory effects on PCR. Viral RNA of 3862 IAV‐negative samples and 171 IAV‐positive samples stored at −80°C following examination for IAV for up to two years was examined in batches for influenza virus types B, C and D, and re‐examined for influenza A virus. Reference IAVs, IBVs, ICVs and IDVs of swine and other host species were retrieved from the reference collections at Friedrich‐Loeffler‐Institut, Greifswald‐Insel Riems, Germany, the Robert‐Koch‐Institut, Berlin, Germany (Dr. B. Schweiger), Department of Molecular Biology, University of Salzburg (Dr. R. Vlasak), and Istituto Zooprofilattico Sperimentale della Lombardia e dell' Emilia Romagna, Italy (Dr. E. Foni), and used for RT‐qPCR validation purposes.

###### 

Number of field samples collected from European domestic swine. IAV‐negative samples were collected from April 2015 until March 2017 from twelve European countries (A). Samples from IAV‐positive farms were taken in October to February in 2015, 2016 and 2017, and all farms were positive for IAV, but not all samples were tested positive (B)

  \(A\)                                                 
  ------- ------- ----- ----- ----- ------- ----- ----- -----
  All     3,753   682   631   62    2,391   442   735   180
  DE      1,000   386   ---   ---   688     253   312   133
  FR      1,166   122   312   28    703     77    151   17
  NL      726     82    138   16    524     57    64    9
  DK      282     27    51    3     152     16    79    8
  ES      198     21    52    6     117     12    29    3
  BE      109     16    22    4     77      11    10    1
  UK      156     15    46    4     60      6     50    5
  IRL     80      8     ---   ---   60      6     20    2
  PT      14      2     10    1     4       1     ---   ---
  AT      2       1     ---   ---   2       1     ---   ---
  PL      10      1     ---   ---   ---     ---   10    1
  SE      10      1     ---   ---   ---     ---   10    1

  \(B\)                                                              
  --------------- --------------------------------- ---- ----- ----- -----
  All             BE, DE, DK, ES, FR, IRL, NL, UK   25   280   171   109
  October 2015    FR, UK                            2    22    14    8
  November 2015   BE, DK, FR                        4    62    55    7
  February 2016   ES, NL                            4    68    39    29
  October 2016    DE, FR, IRL, NL                   6    62    37    25
  November 2016   DE                                2    5     4     1
  January 2017    DE, DK, ES                        7    61    22    39

John Wiley & Sons, Ltd

![Collection sites of the field samples. Maps were calculated based on latitude and longitude data with the online tool Microreact (<http://www.edge.microreact.org/>).[41](#irv12613-bib-0041){ref-type="ref"} Part A shows all collection sites distributed over Middle Europe, and Part B shows the location of the positive samples (orange: IBV; green: IDV)](IRV-13-71-g001){#irv12613-fig-0001}

2.2. Design of primers and probes {#irv12613-sec-0009}
---------------------------------

Primers and probes for detection of IAV, IBV, ICV and IDV for use in a tetraplex RT‐qPCR were selected from previously published assays \[M1.2: Hoffmann et al[38](#irv12613-bib-0038){ref-type="ref"}; IBV_HA: Hopkins et al[39](#irv12613-bib-0039){ref-type="ref"} modified; panIDV_HEF_fwd: Ducatez et al[36](#irv12613-bib-0036){ref-type="ref"}\]. In addition, further primers and probes were designed based on alignments comprising full‐length IBV‐NP, ICV‐M, ICV‐HEF, IDV‐NP and IDV‐HEF sequences extracted from the National Center for Biotechnology Information (NCBI) GenBank database (<https://www.ncbi.nlm.nih.gov/genbank/>), Influenza Research Database (IRD) (<https://www.fludb.org/>) and the Global Initiative on Sharing All Influenza Data (GISAID) EpiFlu^™^ Database (<http://platform.gisaid.org/>). Melting temperatures and basic properties of oligonucleotides were approximated using the online tool "Oligocalc".[40](#irv12613-bib-0040){ref-type="ref"} Primer and probe sets (Table [2](#irv12613-tbl-0002){ref-type="table"}A) were evaluated using strains of the reference collections (Table [3](#irv12613-tbl-0003){ref-type="table"}). Based on these results and on comparisons with published assays, further rounds of optimizing oligonucleotide sequences were initiated. Table [2](#irv12613-tbl-0002){ref-type="table"}A,B lists final sets of primers and probes for RT‐qPCRs (A) and conventional RT‐PCRs (B).

###### 

Attributes of primers and probes employed in the ABCD tetraplex RT‐qPCR (A) or in conventional uniplex RT‐PCRs (B) for the detection of IAV, IBV, ICV and IDV

  \(A\)                                                                                                                         
  ------------ --------------- -------------------------------------- ----------- -------- ------------------------------------ --------------------------------------------------------
  IAV_M1.2_M                                                                                                                    
  IAV‐M1‐F     10 pmol/rxn     agatgagtcttctaaccgaggtcg               (‐2)‐22     101 bp   A/Regensburg/D6/2009                 Hoffmann et al[38](#irv12613-bib-0038){ref-type="ref"}
  IAV‐M1.1‐R   15 pmol/rxn     tgcaaaaacatcttcaagtytctg               76‐99                (H1N1pdm) \[M\]                      modified
  IAV‐M1.2‐R   15 pmol/rxn     tgcaaagacactttccagtctctg               76‐99                FN401576                             
  IAV‐M1‐FAM   1,25 pmol/rxn   FAM‐tcaggccccctcaaagccga‐BHQ1          49‐68                                                     
  IBV_HA                                                                                                                        
  IfB‐F        10 pmol/rxn     aaatacggtggattaaataaaagcaa             940‐965     170 bp   B/Brisbane/60/2008 \[HA\]            Hopkins et al[39](#irv12613-bib-0039){ref-type="ref"}
  IfB‐R        10 pmol/rxn     ccagcaatagctccgaagaaa                  1089‐1109            CY115151                             modified
  IfB_P        1,25 pmol/rxn   ROX‐cacccatattgggcaatttcctatggc‐BHQ2   994‐1020                                                  
  ICV_M                                                                                                                         
  FluC‐F       10 pmol/rxn     cataattgaacttgtcaatggt                 921‐942     94 bp    C/JJ/1950 \[M\]                      
  FluC‐R       10 pmol/rxn     catcgagtcaatttcaggca                   995‐1014             FR671424                             
  FluC‐P       1,25 pmol/rxn   Cy5‐tccacaccatctctcccatctgcc‐BHQ2      952‐975                                                   
  IDV_NP                                                                                                                        
  D_NP_F       10 pmol/rxn     cttgaaaagattgcaaatgcag                 220‐241     99 bp    D/swine/Italy/199724‐3/2015 \[NP\]   
  D_NP_R       10 pmol/rxn     gttgggtttcagtgccattc                   299‐318              KT592534                             
  D_NP_SO      1,25 pmol/rxn   Hex‐cactacatttcccagctgttgactcc‐BHQ1    264‐289                                                   

  \(B\)                                                                                                           
  --------------- ------------ ----------------------- ----------- -------- ------------------------------------- -------------------------------------------------------
  panIBV_NP                                                                                                       
  IBV_SIV_F       5 pmol/rxn   agaugaaugaugucuguuucc   608‐628     340 bp   B/Brisbane/60/2008 \[NP\]             
  IBV_SIV_R       5 pmol/rxn   agggttagrtcttcaatgtc    928‐947              CY115154                              
  panICV_HEF                                                                                                      
  ICV_SIV_F       5 pmol/rxn   aacugauaccacuguaacc     1305‐1323   252 bp   C/JJ/1950 \[HEF\]                     
  ICV_SIV_R       5 pmol/rxn   tcatgagaaatyctgtcattc   1557‐1577            FR671422                              
  panIDV_HEF                                                                                                      
  FluD_HE‐1267F   5 pmol/rxn   cccaagtatggcagatg       1243‐1259   266 bp   D/swine/Italy/199724‐3/2015 \[HEF\]   Ducatez et al[36](#irv12613-bib-0036){ref-type="ref"}
  IDV_SIV_R       5 pmol/rxn   ttgtcaaatccagcctgc      1515‐1532            KT592533                              

rxn---volume reaction of 25 μL.
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###### 

Analytical specificity of primers and probes for detection and discrimination of influenza virus types A, B, C and D. Results are based on the ABCD tetraplex RT‐qPCR

  Strain                                       Subtype/Lineage   RT‐qPCR \[cq‐values\]   PCR target   Accession number                        
  -------------------------------------------- ----------------- ----------------------- ------------ ------------------ ------- ------- ---- ----------------------------------------------------------------
  A/Fort Monmoth/1/1947                        H1                N1                      16.74        neg                neg     neg     MP   [EPI240880](EPI240880), [CY045781](CY045781)
  A/Wild duck/Germany/WV30/2006                H1                N1                      18.01        neg                neg     neg     MP   [EPI248511](EPI248511)
  A/White‐fronted goose/Germany‐NI/R482/2009   H1                N1                      18.3         neg                neg     neg     MP   no MP Seq. \[HA [EPI248525](EPI248525)\]
  A/Germany/Regensburg/2009                    H1pdm             N1pdm                   19.54        neg                neg     neg     MP   [FJ970928](FJ970928)
  A/Germany‐MV/R26/2011                        H1pdm             N1pdm                   18.04        neg                neg     neg     MP   [EPI356425](EPI356425)
  A/Swine/Belzig/2001                          H1av              N1av                    14.26        neg                neg     neg     MP   [EPI236901](EPI236901), [DQ102484](DQ102484)
  A/Swine/Germany/R819/2010                    H1av              N1av                    15.99        neg                neg     neg     MP   [EPI411926](EPI411926)
  A/Swine/Germany/R1738/2010                   H1av              N1av                    17.66        neg                neg     neg     MP   no MP Seq. \[HA [EPI411955](EPI411955)\]
  A/swine/Germany‐NI/R369/09                   H1 av             N2                      19.37        neg                neg     neg     MP   [EPI411878](EPI411878)
  A/swine/Bakum/1832/2000                      H1hu              N2                      17.41        neg                neg     neg     MP   [EPI99278](EPI99278), [DQ186977](DQ186977)
  A/swine/Germany‐NI/R757/10                   H1hu              N2                      15.44        neg                neg     neg     MP   [EPI411916](EPI411916)
  A/Swine/Germany‐NI/R3394/2009                H1hu              N1av                    16.01        neg                neg     neg     MP   [EPI411892](EPI411892)
  A/Swine/Germany/R75/2011                     H1pdm             N2                      14.61        neg                neg     neg     MP   [EPI356461](EPI356461)
  A/Swine/Germany‐NW/R708/2010                 H1pdm             N1av                    18.54        neg                neg     neg     MP   [EPI301660](EPI301660)
  A/Swine/Bakum/909/1993                       H3                N2                      19.03        neg                neg     neg     MP   [EPI174502](EPI174502), [EU478801](EU478801)
  A/Swine/Germany/R96/2011                     H3                N2                      14.48        neg                neg     neg     MP   no MP Seq. \[HA [EPI411978](EPI411978)\]
  A/Swine/Germany/R76/2011                     H3                N2                      17.77        neg                neg     neg     MP   no MP Seq. \[HA [EPI411965](EPI411965)\]
  B/Beijing/1/94                               B                 Yamagata                neg          14.66              neg     neg     HA   [EPI4555](EPI4555), [AF059988](AF059988)
  B/Jiangsu/10/2003                            B                 Yamagata                neg          16.3               neg     neg     HA   [EPI159946](EPI159946), [CY033844](CY033844)
  B/Massachusetts/02/2012                      B                 Yamagata                neg          13.86              neg     neg     HA   [KC892118](KC892118)
  B/Malaysia/2506/2004                         B                 Victoria                neg          16.58              neg     neg     HA   [EPI175755](EPI175755), [CY038287](CY038287)
  B/Brisbane/60/2008                           B                 Victoria                neg          28.37              neg     neg     HA   [EPI173277](EPI173277), [FJ766840](FJ766840)
  C/JJ/1950                                    C                                         neg          neg                21.09   neg     MP   [EPI283751](EPI283751), [FR671424](FR671424)
  C/JHB/1/66                                   C                                         neg          neg                23.89   neg     MP   no MP Seq. \[HE [EPI230654](EPI230654), [AY880247](AY880247)\]
  C/Johannesburg/4/67                          C                                         neg          neg                22.99   neg     MP   [EPI816669](EPI816669), [LC123816](LC123816)
  C/NewJersey/76                               C                                         neg          neg                21.26   neg     MP   [EPI231872](EPI231872), [AB099600](AB099600)
  C/Greece/79                                  C                                         neg          neg                21.77   neg     MP   [EPI231604](EPI231604), [AB099602](AB099602)
  C/Yamagata/3/2000                            C                                         neg          neg                21      neg     MP   [EPI231953](EPI231953), [AB099582](AB099582)
  C/Miyagi/4/2002                              C                                         neg          neg                23.43   neg     MP   [EPI816678](EPI816678), [LC123825](LC123825)
  C/Yamagata/15/2004                           C                                         neg          neg                20.93   neg     MP   [EPI816685](EPI816685), [LC123832](LC123832)
  C/Yamagata/3/2005                            C                                         neg          neg                22.22   neg     MP   [EPI816695](EPI816695), [LC123842](LC123842)
  C/Yamagata/1/2007                            C                                         neg          neg                22.1    neg     MP   [EPI816706](EPI816706) [LC123853](LC123853)
  C/Yamagata/2/2010                            C                                         neg          neg                22.01   neg     MP   [EPI816712](EPI816712), [LC123859](LC123859)
  D/swine/Italy/199724‐3/2015                  D                                         neg          neg                neg     26.59   NP   [KT592534](KT592534)
  D/swine/Oklahoma/1334/2011                   D                                         neg          neg                neg     29.74   NP   [JQ922309](JQ922309)
  Tetraplex mixture                                                                      FAM          ROX                Cy5     HEX          
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2.3. One‐step RT‐qPCR {#irv12613-sec-0010}
---------------------

The AG‐Path‐ID^™^ One‐Step RT‐PCR Kit (Ambion) was used throughout. Thermocycling conditions on a Bio‐Rad CFX96 real‐time PCR detection system were optimized by adapting annealing time and temperature. These cycling conditions were found to be optimal for the generic ABCD‐specific RT‐qPCR: 10 minutes 45°C, 10 minutes 95°C, 42 cycles each of 15 seconds 95°C ‐ 20 seconds 55°C ‐ 30 seconds 72°C.

2.4. Copy‐based standard for ABCD‐Flu‐specific RT‐qPCRs {#irv12613-sec-0011}
-------------------------------------------------------

For the production of RNA run‐off transcripts, products of the above‐mentioned RT‐qPCRs were generated from the IAV strain A/Regensburg/D6/2009 (M gene), the IBV strain B/Brisbane/60/2008 (HA gene), ICV strain C/JJ/1950 (M gene) and IDV strain D/sw/Italy/199724‐3/2015 (NP gene). Products of the correct size were cloned into the pCR^®^II‐plasmid (Invitrogen) containing T7‐ and Sp6‐promoter sequences following the recommendations of the Topo TA cloning Dual Promoter Kit (Invitrogen, Carlsbad, CA, USA). Inserts of selected clones were sequenced using SP6 and T7 primers. RNA was transcribed with T7 RNA polymerase (Promega, Mannheim, Germany) from plasmids linearized with *Hind*III (NEB, Frankfurt, Germany) according to the manufacturer\'s instructions. Transcribed RNA was further purified by the RNeasy Mini Kit (Qiagen, Hilden, Germany) and quantified using the NanoDrop ND‐1000 Spectrophotometer (PEQLAB Biotechnologies, Erlangen, Germany). Calculation of the RNA copy number was done by the online tool Endmemo ([www.endmemo.com/bio/dnacopynum.php/](http://www.endmemo.com/bio/dnacopynum.php/)). Triplicate serial 10‐fold dilutions of the purified transcribed RNAs starting at 10^8^ copies/reaction down to one copy were used in the ABCD tetraplex RT‐qPCR to determine the limit of detection (LOD). Samples with a Cq‐value below 40 were considered positive.

2.5. Conventional one‐step RT‐PCR {#irv12613-sec-0012}
---------------------------------

The Superscript III One‐Step RT‐PCR Kit with Platinum Taq polymerase (Invitrogen) was used for conventional RT‐PCR. Thermocycling conditions on an Analytik Jena Flex Cycler or a SensoQuest Labcycler were optimized to the following conditions for generic panIBV_NP, panICV_HEF and panIDV_HEF RT‐PCRs: 30 minutes 48°C, 2 minutes 94°C, 45 cycles each of 30 seconds 94°C ‐ 30 seconds 55°C ‐ 40 seconds 68°C, final elongation 2 minutes 68°C.

2.6. Sequencing {#irv12613-sec-0013}
---------------

IBV, ICV or IDV PCR‐positive field samples were analysed by Sanger sequencing of the IBV‐NP, ICV‐HEF, IDV‐HEF gene fragments obtained with the panIBV_NP (340 bp), panICV_HEF (250 bp) and panIDV_HEF (260 bp) conventional RT‐PCRs (Table [2](#irv12613-tbl-0002){ref-type="table"}B). Specific amplicons were purified from 1.5% agarose gels using a QIAquick Gel Extraction Kit (Qiagen) and Sanger‐sequenced using the RT‐PCR primers. The sequences were analysed on an ABI 310 sequencer, curated using the Chromas Lite^®^ software (<http://www.technelysium.com.au/Chromas250Setup.exe>) and assembled using the Geneious^®^10.2.3 software suite (Biomatters Ltd., Auckland, New Zealand).

2.7. Molecular sequence analyses {#irv12613-sec-0014}
--------------------------------

The IRD (<https://www.fludb.org/>) or GISAID EpiFlu^™^ (<http://platform.gisaid.org/>) Databases were screened with the BLASTN2 algorithm to identify closely related sequences of the panIBV_NP, panICV_HEF and panIDV_HEF sequences.

2.8. Virus isolation on cell culture {#irv12613-sec-0015}
------------------------------------

Madin‐Darby canine kidney 2 (MDCK‐2, ATCC^®^ CRL‐2936^™^) grew in minimum essential medium (MEM) with 5% foetal calf serum (FCS) in 25‐cm^2^ culture flasks (Corning, Nuembrecht, Germany). For isolation of the positive field samples, medium was replaced with infectious material and incubated for 1 hour at 37°C. After incubation, MEM with 6‐ (1‐tosylamido‐2‐phenyl) ethyl chloromethyl ketone (TPCK)‐treated trypsin was added. After 72 hours, supernatants of the cultures were passaged once after a freeze‐thaw‐step, regardless of a recognizable cytopathic effect (CPE).

2.9. Mapping of farm locations {#irv12613-sec-0016}
------------------------------

Maps of the collection sites of the field samples were calculated based on latitude and longitude data with the online tool Microreact (<http://www.edge.microreact.org/>).[41](#irv12613-bib-0041){ref-type="ref"}

3. RESULTS {#irv12613-sec-0017}
==========

3.1. Assembly and analytical performance of an influenza virus type‐specific ABCD tetraplex RT‐qPCR for the simultaneous detection and differentiation of IAV, IBV, ICV and IDV in porcine samples {#irv12613-sec-0018}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Various primer/probe sets, either published or newly developed, were tested in monoplex RT‐qPCRs for their sensitivity and specificity using RNA extracted from reference isolates (data not shown). A panel of RNA containing 36 influenza virus strains were used to evaluate different sets of primers and probes for their analytical specificity for four different influenza lineages (Table [3](#irv12613-tbl-0003){ref-type="table"}): 17 IAVs of subtypes H1, H3, N1 and N2 of human, avian or porcine origin; five IBVs of the Yamagata and Victoria lineages of human origin; and eleven ICVs of human origin and two IDVs of porcine origin. Oligonucleotide sets were further selected for a combined ABCD tetraplex RT‐qPCR on the basis that no intersubtypic cross‐reactivity occurred and inhibitory interferences were excluded. The final selection comprised previously published but slightly modified sets for the detection of IAV and IBV,[38](#irv12613-bib-0038){ref-type="ref"}, [39](#irv12613-bib-0039){ref-type="ref"}, [42](#irv12613-bib-0042){ref-type="ref"}, [43](#irv12613-bib-0043){ref-type="ref"} and newly developed sets for the detection of ICV and IDV (Table [2](#irv12613-tbl-0002){ref-type="table"}A,B). This set fulfilled the mentioned requirements as shown in Table [3](#irv12613-tbl-0003){ref-type="table"}. Non‐specific reactivity of these PCRs with other porcine viral or bacterial respiratory pathogens as listed in Supplementary Table [1](#irv12613-tbl-0001){ref-type="table"} was excluded as well.

Copy‐based standards were used to determine the limit of detection of the tetraplex RT‐qPCR (Figure [2](#irv12613-fig-0002){ref-type="fig"}). An LOD of 10 target copies was evident for all four targets when only a single of the four targets was present.

![Analysis of the detection limit of the ABCD tetraplex RT‐qPCR based on the mean value of triplicate serial 10‐fold dilutions of transcribed viral RNA ranging from 10^8^ to 1 copies/reaction (A1‐D1). Linear regression analysis revealed correlation coefficients (R2) and slope values (A2‐D2). A, IAV,FAM signal; B, IBV,ROX signal; C, ICV, Cy5 signal; D, IDV,HEX signal](IRV-13-71-g002){#irv12613-fig-0002}

To prove the sensitivity of the tetraplex RT‐qPCR for potential mixed infections of IAV with either IBV, ICV or IDV, IAV‐positive swine nasal samples with initial cq‐values of 20, 25 and 30 were spiked with IBV‐, ICV‐ or IDV‐RNA at a cq‐value of 30. Additional mock samples (PBS) and IAV‐negative swine nasal samples were likewise mixed with IBV‐, ICV‐ or IDV‐RNA as indicated above. Samples were tested three times with the ABCD tetraplex RT‐qPCR. The majority of the B/C/D‐spiked samples yielded results in the frame of the original cq‐value of 30, with the exception of the mixes IAV‐cq 20 + IBV‐cq 30 where IBC cq‐values close to the upper detection threshold of cq 40 resulted (Figures [3](#irv12613-fig-0003){ref-type="fig"}A,B, Table [S2](#irv12613-sup-0002){ref-type="supplementary-material"}). In reverse fashion, further mixtures of IBV, ICV and IDV with initial cq‐values of 20, 25 and 30 were spiked with IAV at cq 30 and were tested . In addition, triple and 4‐fold mixtures were examined as well. All yielded results close to the initial cq‐values (Table [S2](#irv12613-sup-0002){ref-type="supplementary-material"}).

![Analysis of the sensitivity of the ABCD tetraplex RT‐qPCR in simulated co‐infections. IAV‐positive swine nasal samples with cq‐values of 20, 25 and 30, and IAV‐negative swine samples and PBS were mixed with RNA of either IBV (A), ICV (B) or IDV (C) each of Cq = 30. Mixtures were analysed three times in the RT‐qPCR](IRV-13-71-g003){#irv12613-fig-0003}

3.2. Diagnostic performance of the influenza virus type‐specific ABCD tetraplex RT‐qPCRs {#irv12613-sec-0019}
----------------------------------------------------------------------------------------

### 3.2.1. Screening for IBV, ICV and IDV in European domestic swine populations April 2015‐March 2017 {#irv12613-sec-0020}

Only three IAV‐negative samples from three different farms yielded a positive RT‐qPCR result for either IBV or IDV, albeit with high cq‐values, (Table [4](#irv12613-tbl-0004){ref-type="table"}, Figure [1](#irv12613-fig-0001){ref-type="fig"}B). To exclude the possibility of false‐positive results due to sample or PCR contamination, re‐extracted RNA of these samples was examined in conventional IBV‐ or IDV‐specific RT‐PCRs as listed in Table [1](#irv12613-tbl-0001){ref-type="table"}B. Sequence analysis of these amplicons confirmed the findings of the ABCD tetraplex RT‐qPCR (sequences listed in Table [S3](#irv12613-sup-0003){ref-type="supplementary-material"}). The two confirmed IBV‐positive cases were detected in samples from the Netherlands (age of swine unknown) and Germany (adult sow), respectively. Temporally, the detection was made in samples collected between May and September, which is well outside the human influenza season in these countries. The IDV case was found in a swine of unknown age in Germany. No ICV‐positive porcine samples were detected. Expectedly, no IAV‐positive results were obtained as a pre‐selection of IAV‐negative samples was used here.

###### 

Field samples positive for IBV and IDV. Results are based on the ABCD tetraplex RT‐qPCR and conventional uniplex RT‐PCR

  Sample[a](#irv12613-note-0002){ref-type="fn"}   Result   Country   Collection month   Specimen     Swine category   RT‐qPCR \[cq‐value\]   RT‐PCR     Closely related virus \[identity\]
  ----------------------------------------------- -------- --------- ------------------ ------------ ---------------- ---------------------- ---------- ---------------------------------------------------
  AR 3087/16                                      IBV      NL        May 2016           Nasal swab   No data          35.73 (IBV)            \+ (IBV)   B/Santa Cruz/194/2012; NP \[281/283 (99%)\]
  AR 6877/16                                      IBV      DE        September 2016     Nasal swab   Sow              37.76 (IBV)            \+ (IBV)   B/New York/1231/2009; NP \[297/299(99%)\]
  AR 4484/16                                      IDV      DE        July 2016          Nasal swab   No data          34.24 (IDV)            \+ (IDV)   D/swine/Oklahoma/1334/2011; HEF \[188/196 (95%)\]

Sample indicates the identity of a sample (AR NNNN) and the year of sampling (/YR).

John Wiley & Sons, Ltd

Madin‐Darby canine kidney cell culture isolation of the two IBV‐ and the IDV‐positive samples was unsuccessful ruling out further analysis. Serological studies of the farms which tested positive for IBV and IDV could not been carried out, since serum samples were not available and the animals no longer retrievable on the farms.

To detect possible co‐infection of IAV with any of the three other influenza virus types, 171 IAV‐positive samples from 25 farms of eight European countries were analysed in addition (Table [1](#irv12613-tbl-0001){ref-type="table"}B). The cq‐values initially obtained by monoplex IAV screening when the samples were submitted and the IAV cq‐value obtained by ABCD tetraplex RT‐qPCR after storage of RNA for up to 26 months at −80°C differed only slightly, as shown in Figure [4](#irv12613-fig-0004){ref-type="fig"}. This indicated stability over time of the RNAs analysed. None of these 171 IAV‐positive porcine samples yielded IBV, ICV or IDV.

![Comparison of the IAV cq‐values from the initial (monoplex‐) IAV screening and the cq‐values of the IAV (BCD)‐tetraplex RT‐qPCR. First screening was done within a week of sample receipt; thereafter, RNA was stored at −80°C up to 26 months. Cut‐off for the ABCD tetraplex RT‐qPCR was set at cq 40](IRV-13-71-g004){#irv12613-fig-0004}

4. DISCUSSION {#irv12613-sec-0021}
=============

The zoonotic propensity of porcine IAV is well established and has been demonstrated impressively during the human H1N1 pandemic of 2009.[2](#irv12613-bib-0002){ref-type="ref"}, [35](#irv12613-bib-0035){ref-type="ref"} In this respect, it is astonishing to note that, in Europe, after the discontinuation of the ESNIP3 monitoring programme,[37](#irv12613-bib-0037){ref-type="ref"} so far only France runs a sustained government‐administrated surveillance programme targeting IAV in swine populations.[44](#irv12613-bib-0044){ref-type="ref"}, [45](#irv12613-bib-0045){ref-type="ref"}, [46](#irv12613-bib-0046){ref-type="ref"} No efforts have been undertaken to gather knowledge on putative IBV and ICV infections in European swine although sporadic incidents had been reported in the past.[20](#irv12613-bib-0020){ref-type="ref"}, [21](#irv12613-bib-0021){ref-type="ref"}, [25](#irv12613-bib-0025){ref-type="ref"} IDV likewise was not a target of investigation programmes, with the exception of some IDV screening in Italian swine, showing a virus prevalence of 2% and a seroprevalence of 11.7%, and serological studies in Luxembourgian swine showing an increasing seroprevalence from 0 to 5.9% in the years 2012‐2015.[31](#irv12613-bib-0031){ref-type="ref"}, [32](#irv12613-bib-0032){ref-type="ref"}, [36](#irv12613-bib-0036){ref-type="ref"}

To provide a cost‐effective tool that enables, in standard molecular diagnostic laboratories, the simultaneous and high‐throughput screening of four influenza virus types in porcine samples, we successfully have developed an ABCD tetraplex RT‐qPCR. Analytical and diagnostic performance characteristics proved this PCR fit for purpose.

An ongoing, industrial‐funded passive surveillance project for porcine IAV intended as a follow‐up of the ESNIP3 programme in Europe provided samples from pigs with respiratory disease. The primary interest of the present study, however, was not on IAV but focused on IBV, ICV and IDV infections. Thus, a pre‐selection of IAV‐negative samples from swine with respiratory disease was used which comprised 3,753 samples from 682 farms collected in twelve European countries. These samples yielded only two swabs that were positive with low virus loads for IBV (one sample each from the Netherlands and from Germany), and IDV was detected in only one German sample, no case of ICV was seen. Nevertheless, evidence of an IBV infection was confirmed for the first time in European swine and an IDV infection was not previously reported from pigs in Germany. It is of interest to note that the IBV detections occurred during the summer period when no human influenza activity is registered in Europe. Thus, it remains unclear whether the IBV detected here in swine originated from a temporally closely associated human‐to‐swine transmission. Considering that no IBV reservoir in animals has been identified so far, this would suggest limited but autonomous replication of IBV in some swine populations. Unfortunately, it was not possible to trace sources and spread of the IBV and IDV infections in the respective swine holdings. Narrow‐meshed, regionally focused virological as well as serological surveillance including also healthy pigs would be required to clarify the actual prevalence of IBV and IDV in swine populations.

Information on possible co‐infections with IAV and the other influenza virus types in swine is not available; in humans, co‐infection of IAV/IBV was seen in 1.6% of a case study.[47](#irv12613-bib-0047){ref-type="ref"} This aspect was addressed by examining an additional 171 samples from 25 farms with swine acutely infected with IAV. However, none were positive for IBV, ICV or IDV. These samples were obtained during the human flu season in 2016 and 2017 (January‐April), when low IBV activity was confirmed in humans.

Samples analysed in this study were not representative for the swine populations in the different European countries; it is therefore not possible to draw conclusions regarding the true incidence of influenza virus infections. Also, no data from healthy swine have been collected, since the samples originated from passive surveillance targeting only swine with acute respiratory disease; a similar knowledge gap also exists for IAV infections in healthy pigs. A broader approach by an active surveillance for influenza virus types would be required to better understand endemic circulation at least of IAV in larger swine holdings. The newly developed tetraplex RT‐qPCR is an appropriate tool for this purpose which may also cast further light on potential reverse zoonotic transmission events of IBV and ICV and the presence of IDV in swine populations. In addition, the ABCD tetraplex RT‐qPCR should also be useful in screening samples of other host species including man. Therefore, projects aiming at the examination of influenza virus transmission at the swine‐human interface might benefit from this tool.

Supporting information
======================

###### 

 

###### 

Click here for additional data file.

###### 

 

###### 

Click here for additional data file.

###### 

 

###### 

Click here for additional data file.

We thank Aline Maksimov, Diana Parlow, Sina Ramcke and Carl Sell for excellent technical assistance, as well as Dr. Ilona Reimann and Gabriela Adam for help with RNA transcripts.

Reference influenza strains were kindly made available by Dr. B. Schweiger, Robert‐Koch‐Institut (RKI), Berlin, Germany (human IAV and IBV); Dr. R. Vlasak, University of Salzburg (ICV); and Dr. E. Foni, Istituto Zooprofilattico Sperimentale della Lombardia e dell' Emilia Romagna (IZSLER), Italy (IDV).

Nucleic acid of non‐influenza porcine reference pathogens was kindly provided by Andrea Menrath, Hannover Veterinary School, Germany, and Kerstin Wernike, Friedrich‐Loeffler‐Institut, Germany.

The study has been funded by grants from IDT Biologika, Dessau, Germany (project Ri‐0402). We thank all practicing veterinarians who keep on submitting swine samples for influenza A virus monitoring.

We thank all practicing veterinarians who keep on submitting swine samples for influenza A virus monitoring.
